Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity. |
eNq1mF1v2jAUhu/5FVEudkdCKKF0S0AbazekVmO0aNNukEkOYBbs1B9A9+vnEFDp5KirwZeJk/cc+xw/fuWot11lzhoYx5TEbuA1XAdIQlNM5rE7fripd9xetxYt0RodfXbpNbyg6TpJhjiP3WLUmwIi3Pt5d/sZ1P/A3G7Nieh0CYl48Z0UOPO+Ir64Q3nxjROtKU6dFYgFTWM3l2L31om4YCqL7oay3zxHCUT+/s3x6HLSOn4f+YXYf6hKDuwWkblWFIiRZiIZAyL6SMCcsqeKfC+MtDEfAaeSJTBEYjFkdI1TSLUhZijjYBRktknvga0zEEUQrbi/TFbcSBwt0XYEjwN90h/VaF9sRb1RDy7DVtgOgrARtBtGodjRUumroCbhJ5PLZtgMrnwg/grNCdSnbcPaDCkTKLNUFcz7LxvLUhwGj69WP8U8z9CTt+S56VIhhtQwMLX97U2kmMEDU0DK1Jr9o09klvlvzHq8x4WljAsa9akkooIaNyPThehTImBbXVEz0Intvhcx8PPJ/qFED/mhnGY4MUWago4ELsajQTXRzgmDT4jDmNmjwQ9MUrrh56fMcVUtZZ/vQKkVzVkaTJpXnXYQhsab6JdqoYoT5loymoOv+IP5KVgZkBk9FSiqK/VSh548WzvufA5NUAYVTqduyBbVhwdjZq3T7e2ickAr+uX6wbQ9vktgT/e7R600TuNDYc24awPmqhdfy7vctXE+uWiEnauL1ju0yj8cHHRs6JZLUStmWTI9YhZC5Py97282G2+BeJ0jtZ7ejFUfAT3t1M8xfcXb52ra8/NWzv/SD5WstZT6tDxE31ZG0337mkM41fXu/9+7a20MwSScUIsS8dZAPLg+P9ufLa+1tIcvEGMvzM6eIoEpsWWb5FSreNJpospKbpjiw7fZDFdcr1S2ZeSXVzvdWuQX1zrd2l9Evv6R
uHLKMHAYDxExbAR7
Listen
